Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
3.810
-0.180 (-4.51%)
Nov 16, 2026, 4:00 PM EST - Market closed

Vanda Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
61.9384.85102.32135.82135.0352.07
Short-Term Investments
78.56179272.33252.44331.83380.74
Cash & Short-Term Investments
140.49263.85374.64388.26466.86432.81
Cash Growth
-52.17%-29.57%-3.51%-16.84%7.87%17.70%
Receivables
60.3254.5847.134.1633.5132.47
Inventory
1.531.851.731.361.191.03
Prepaid Expenses
36.1326.8815.429.176.2312
Restricted Cash
-0.1----
Other Current Assets
----11.5-
Total Current Assets
238.47347.26438.89432.95519.29478.3
Property, Plant & Equipment
23.213.5112.689.1410.9712.39
Other Intangible Assets
111.13117.09114.1121.3718.5720.08
Long-Term Deferred Tax Assets
--81.447574.0474.88
Other Long-Term Assets
9.5311.089.19.9911.388.15
Total Assets
382.33488.95656.2648.44634.25593.79

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
7.984.943.57.1512.690.93
Accrued Expenses
47.9347.831.3228.9230.5331.2
Current Portion of Leases
4.685.564.272.42.332.31
Other Current Liabilities
94.3986.8760.949.2445.8939.98
Total Current Liabilities
154.98145.1699.9887.791.4474.42
Long-Term Leases
17.297.078.097.018.8110.06
Other Long-Term Liabilities
10.29.539.598.836.84.39
Total Liabilities
182.47161.76117.66103.53107.0588.86

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.060.060.060.060.060.06
Additional Paid-In Capital
728.27721.26712.71700.27686.24669.22
Retained Earnings
-528.41-394.77-174.29-155.39-157.9-164.18
Comprehensive Income & Other
-0.070.630.07-0.03-1.19-0.18
Shareholders' Equity
199.86327.19538.55544.91527.2504.93
Total Liabilities & Equity
382.33488.95656.2648.44634.25593.79

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
21.9712.6212.369.411.1412.37
Net Cash (Debt)
118.52251.23362.28378.86455.72420.45
Net Cash Growth
-58.09%-30.65%-4.38%-16.86%8.39%18.73%
Net Cash Per Share
1.984.266.236.588.007.39
Filing Date Shares Outstanding
60.4759.1158.3257.5456.7955.91
Total Common Shares Outstanding
60.4759.158.3157.5356.7855.9
Working Capital
83.49202.1338.91345.25427.86403.88
Book Value Per Share
3.315.549.249.479.289.03
Tangible Book Value
88.73210.1424.45423.54508.63484.85
Tangible Book Value Per Share
1.473.557.287.368.968.67
Machinery
-9.378.237.787.587.03
Leasehold Improvements
-5.55.475.445.425.46
SEC Filings: 10-K · 10-Q